RG6496
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RG6496, covering 2026-03-30 to 2026-03-30. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RG6496 in Huntington's Disease [Phase 1]